Doxycycline and Menaquinone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Doxycycline (doxycycline hyclate) and Menaquinone (vitamin k). Common drug interactions include insomnia among females.

The phase IV clinical study analyzes what interactions people have when they take Doxycycline and Menaquinone. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Doxycycline?

Doxycycline has active ingredients of doxycycline hyclate. It is often used in acne. eHealthMe is studying from 60,868 Doxycycline users. Check the latest studies of Doxycycline.

What is Menaquinone?

Menaquinone has active ingredients of vitamin k. eHealthMe is studying from 775 Menaquinone users. Check the latest studies of Menaquinone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 25, 2026

13 people who take Doxycycline and Menaquinone together, and have interactions are studied.

Doxycycline and Menaquinone drug interactions.

What are the common drug interactions of Doxycycline and Menaquinone, by gender? *:

female:

  1. Insomnia (sleeplessness)
  2. Pain in extremity
  3. Speech disorder
  4. Wound infection
  5. Fatigue (feeling of tiredness)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Acquired oesophageal web (structural abnormalities in the oesophagus)
  8. Chills (felling of cold)
  9. Cough
  10. Cystitis (inflammation of the wall of the bladder)

male:

n/a

What are the common drug interactions of Doxycycline and Menaquinone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Cough
  2. Diarrhoea
  3. Dry eye (lack of adequate tears)
  4. Dyspnoea (difficult or laboured respiration)
  5. Fluid retention (an abnormal accumulation of fluid in the blood)
  6. Headache (pain in head)
  7. Influenza
  8. Insomnia (sleeplessness)
  9. Memory impairment
  10. Nocturnal dyspnoea (attacks of severe shortness of breath and coughing that generally occur at night)

50-59:

  1. Pain in extremity
  2. Urinary tract infection
  3. Abdominal discomfort
  4. Insomnia (sleeplessness)
  5. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  6. Muscle twitching
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Speech disorder
  9. Cystitis (inflammation of the wall of the bladder)
  10. Headache (pain in head)

60+:

  1. Acquired oesophageal web (structural abnormalities in the oesophagus)
  2. Chills (felling of cold)
  3. Uterine polyp (a mass in the inner lining of the uterus)
  4. Wound infection
  5. Fatigue (feeling of tiredness)
  6. Malaise (a feeling of general discomfort or uneasiness)
  7. Spinal fusion surgery
  8. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)
  9. Precancerous cells present
  10. Decreased appetite

What are the existing conditions these people have? *

  1. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 53.85%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 15.38%
  3. Gait Disturbance: 2 people, 15.38%
  4. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 7.69%
  5. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.69%
  6. Polymyositis (inflammatory muscle disease that causes weakness of the skeletal muscles): 1 person, 7.69%
  7. Nasal Polyps (masses that develop in the lining of the nose): 1 person, 7.69%
  8. Immunodeficiency: 1 person, 7.69%
  9. Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer): 1 person, 7.69%
  10. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Doxycycline and Menaquinone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Doxycycline and Menaquinone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Doxycycline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Menaquinone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Doxycycline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Menaquinone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on doxycycline hyclate and vitamin k (the active ingredients of Doxycycline and Menaquinone, respectively), and Doxycycline and Menaquinone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: